Prevent Contamination and Ensure the Safety of your Biologics - Creating Effective Strategies to Mitigate Risk and Optimise Clearance of Viral, Prion and Mycoplasma Pathogens

As pathogens continue to adapt and develop so must your strategy to prevent contamination. With both the financial cost and the damage to reputation so high is it critical to keep at the cutting edge of the latest technologies and the newest strategies to optimise your security.

Our expert speaker panel share:

• Exclusive data on the implementation of deep sequencing technologies from Genzyme
• The latest regulatory updates on viral vaccine safety from the FDA’s Dr Arifa Khan
• Benchmark against your peers with different approaches to mitigating risk with case studies from Biogen Idec and Baxter bioscience
• NIH’s Rebecca Sheets looks at best practices for viral safety screening and effectively rationalising the use of new technologies
• Protect your biologics from the latest agents with input from Phil Minor, NIBSC

2012 is the most interactive event yet maximising the networking with the experts. Join panel discussions, open forums, crisis management sessions and round table sessions to not only learn from others experiences but to discuss your own case studies on a peer to peer level.

This year we apply the Chatham House Rule, facilitating an environment to safely share, discuss and learn with peers from across the industry.

Join us this October in Munich to learn from regulatory bodies, industry experts and academic representatives on how to escape contamination and get your products to market safely, speedily and successfully.

Register here!

Sponsors	Media Partners